It’s an optimistic time for non-small cell lung cancer (NSCLC) treatment. Within the last few years, the pipeline of available therapies and tests has boomed which has changed not only the outlook, but the way medicine is performed in this area. To reflect on how clinicians are managing patients with NSCLC has changed and consider ...
Is it time to take a step back to take the next step forward?
Sponsored by Pfizer Australia
6 Dec 2018